Lipidated glycosaminoglycan particles and their use in drug...

Details Lipidated glycosaminoglycan particles and their use in drug... Lipidated glycosaminoglycan particles and their use in drug...

2002-08-09

2009-06-09

Kishore, Gollamudi S (Department: 1612)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Particulate form

C424S489000, C424S450000

Reexamination Certificate

active

07544374

ABSTRACT:
Lipidated glycosaminoglycan particles are prepared by reacting a glycosaminoglycan with at least one lipid to cross-link the carboxylic acid groups in the glycosaiminoglycan with a primary amine in the lipid. These particles can be used to encapsulate active ingredients, such as drugs for use in the treatment of pathological conditions in an animal.

REFERENCES:
patent: 4235871 (1980-11-01), Papahadjopoulos et al.
patent: 4898735 (1990-02-01), Barenholz et al.
patent: 4902512 (1990-02-01), Ishigami et al.
patent: 4927637 (1990-05-01), Morano et al.
patent: 5143713 (1992-09-01), Phillips et al.
patent: 5401511 (1995-03-01), Margalit
patent: 5614506 (1997-03-01), Falk et al.
patent: 5624839 (1997-04-01), Yada et al.
patent: 5639738 (1997-06-01), Falk et al.
patent: 5674857 (1997-10-01), Falk et al.
patent: 5733892 (1998-03-01), Sakurai et al.
patent: 5783566 (1998-07-01), Mislick
patent: 5792753 (1998-08-01), Falk et al.
patent: 5811410 (1998-09-01), Falk et al.
patent: 5817642 (1998-10-01), Falk et al.
patent: 5824658 (1998-10-01), Falk et al.
patent: 5827834 (1998-10-01), Falk et al.
patent: 5830882 (1998-11-01), Falk et al.
patent: 5834444 (1998-11-01), Falk et al.
patent: 5847002 (1998-12-01), Willoughby et al.
patent: 5852002 (1998-12-01), Falk et al.
patent: 5910489 (1999-06-01), Falk et al.
patent: 5914314 (1999-06-01), Falk et al.
patent: 5914322 (1999-06-01), Falk et al.
patent: 5929048 (1999-07-01), Falk et al.
patent: 5932560 (1999-08-01), Falk et al.
patent: 5942498 (1999-08-01), Falk et al.
patent: 5962433 (1999-10-01), Falk et al.
patent: 5972906 (1999-10-01), Asculai et al.
patent: 5977088 (1999-11-01), Harper et al.
patent: 5985850 (1999-11-01), Falk et al.
patent: 5985851 (1999-11-01), Falk et al.
patent: 5990095 (1999-11-01), Falk et al.
patent: 5990096 (1999-11-01), Asculai et al.
patent: 6017900 (2000-01-01), Falk et al.
patent: 6022866 (2000-02-01), Falk et al.
patent: 6048844 (2000-04-01), Falk et al.
patent: 6069135 (2000-05-01), Falk et al.
patent: 6087344 (2000-07-01), Falk et al.
patent: 6103704 (2000-08-01), Falk et al.
patent: 6114314 (2000-09-01), Falk et al.
patent: 6136793 (2000-10-01), Falk et al.
patent: 6140312 (2000-10-01), Falk et al.
patent: 6147059 (2000-11-01), Falk et al.
patent: 6194392 (2001-02-01), Falk et al.
patent: 6218373 (2001-04-01), Falk et al.
patent: 6593308 (2003-07-01), Szoka, Jr.
patent: 2002/0061849 (2002-05-01), Nielsen et al.
patent: 2002/0131995 (2002-09-01), Szoka, Jr.
patent: 2003/0175733 (2003-09-01), Kirst et al.
Yagi, k. et al, Biochem. Molec. Biol. Internat. vol. 32, pp. 167-171 (1994).
Firth, G. et al. Journal of the Neurological Science, vol. 63, pp. 153-165, 1984.

Affiliated with

Also associated with

Rating

Lipidated glycosaminoglycan particles and their use in drug... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lipidated glycosaminoglycan particles and their use in drug..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lipidated glycosaminoglycan particles and their use in drug... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4097053